Basics Foghorn Therapeutics Inc. IPO Date: October 23, 2020 Sector: Healthcare Industry: Biotech Market Cap: $225.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 4.13% Avg Daily Range (30 D): $0.15 | 3.63% Avg Daily Range (90 D): $0.18 | 4.14% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .09M Avg Daily Volume (90 D): .1M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 89 Avg Trade Size (Sh.) (90 D): 92 Institutional Trades Total Inst.Trades: 80 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.7M Avg Closing Trade (30 D): $1.33M Avg Closing Trade (90 D): $1.33M Avg Closing Volume: 211.87K         News May 1, 2025 @ 11:00 AM Foghorn Therapeutics Appoints Neil Gallagher and S... Source: N/A Apr 15, 2025 @ 11:00 AM Foghorn Therapeutics to Host Virtual Investor Even... Source: N/A Oct 1, 2024 @ 11:00 AM Foghorn Therapeutics to Participate in the BMO Onc... Source: N/A Sep 24, 2024 @ 1:15 PM Optimism Grows in the Fight Against Cancer as Brea... Source: Prnewswire Sep 3, 2024 @ 8:48 PM Wall Street Analysts Think Foghorn Therapeutics Co... Source: Zacks Financials   TTM Q4 2024 FY 2024 Basic EPS $-.3 $-.3 $-1.58 Diluted EPS $-.3 $-.3 $-1.58 Revenue $ 5.95M $ 2.86M $ 22.6M Gross Profit $ $ $ Net Income / Loss $ -18.83M $ -19.5M $ -86.62M Operating Income / Loss $ -22.91M $ -24.01M $ -102.68M Cost of Revenue $ $ $ Net Cash Flow $ 5.57M $ -2.22M $ -24.88M PE Ratio